BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cynosure, Inc. (CYNO) Announces Upcoming Conference Presentations


11/11/2013 10:59:20 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

WESTFORD, Mass., Nov. 11, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today announced that Chairman, Chief Executive Officer and President Michael Davin and Executive Vice President, Chief Operating Officer and Chief Financial Officer Timothy Baker will be presenting at two upcoming investor conferences.

  • On Thursday, November 14 at 10:30 a.m. (ET), management will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York City.
  • On Tuesday, November 19 at 9:05 a.m. (ET), management will participate in a fireside chat at the Barclays Select Growth Conference in New York City.

To access the live or archived webcasts of these events, visit the "Investor Relations" portion of Cynosure's website, www.cynosure.com.

About Cynosure, Inc.
Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, treat toe fungus and ablate sweat glands. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 100 other countries. For corporate or product information, visit Cynosure's website at www.cynosure.com.

Contact:

Scott Solomon
Vice President
Sharon Merrill
617.542.5300
CYNO@investorrelations.com

SOURCE Cynosure, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES